Clinical Trial Update: Sitagliptin for Hyperglycemia in Patients With T2DM Undergoing Cardiac Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating sitagliptin for hyperglycemia in patients with type 2 diabetes undergoing cardiac surgery has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperglycemia
• Type 2 Diabetes Mellitus

Drugs mentioned

• Sitagliptin (sitagliptin)

Snippet

Sponsor: Emory University | Conditions: Hyperglycemia | Phase 4 | Status: COMPLETED | Results posted: 2019-12-23